Michael Wolfe brings twenty years of corporate finance and life science expertise to Kezar. Prior to the launch of Kezar Life Sciences in 2015, Mr. Wolfe served as the Head of R&D Finance at Onyx Pharmaceuticals, Inc. until its’ acquisition by Amgen, Inc. in 2013. Previously, he served in a commercial finance role at Mentor Corporation, a Johnson & Johnson subsidiary, pre-and post-acquisition. Mr. Wolfe’s career in the life sciences sector began at Amgen, Inc. where he held a number of positions of increasing responsibility within the finance organization. He began his finance career at 3Com Corporation, Inc., a leader in the manufacturing and sale of computer networking products, acquired by Hewlett Packard in 2010.
Mr. Wolfe earned a Bachelor of Science, in Business Administration from California Polytechnic State University, San Luis Obispo.